APPENDICES - NIHR Health Technology Assessment Programme

More documents

Recommendations

Info

160 Appendix 8 68. McCaughan JS, Jr, Guy JT, Hawley P, Hicks W, Inglis W, Laufman L, et al. Hematoporphyrin-derivative and photoradiation therapy of malignant tumors. Lasers Surg Med 1983;3:199–209. 69. McCaughan JS, Jr, Hicks W, Laufman L, May E, Roach R. Palliation of esophageal malignancy with photoradiation therapy. Cancer 1984;54:2905–10. 70. McCaughan JS, Jr, Nims TA, Guy JT, Hicks WJ, Williams TE, Jr, Laufman LR. Photodynamic therapy for esophageal tumors. Arch Surg 1989;124:74–80. 71. McCaughan JS, Jr, Williams TE, Jr, Bethel BH. Palliation of esophageal malignancy with photodynamic therapy. Ann Thorac Surg 1985;40:113–20. 72. Messmann H, Holstege A, Szeimies RM, Lock G, Bown SG, Scholmerich J. Photodynamic therapy: a safe and effective treatment for tumor overgrowth in patients with oesophageal cancer and metal stents. Endoscopy 1995;27:629. 73. Messmann H, Szeimies RM, Baumler W, Knuchel R, Zirngibl H, Scholmerich J, et al. Enhanced effectiveness of photodynamic therapy with laser light fractionation in patients with esophageal cancer. Endoscopy 1997;29:275–80. 74. Mimura S, Ichii M, Imanishi K, Otani T, Okuda S. [Indications for and limitations of HpD photodynamic therapy for esophageal cancer and gastric cancer.] Gan To Kagaku Ryoho 1988;15:1440– 4. 75. Mimura S, Narahara H, Ishihara R, Iishi H. Long-term survival after photodynamic therapy with Photofrin for superficial esophageal cancer and early gastric cancer. 14th World Congress of the International Society for Laser Surgery and Medicine, Chennai, India, 2001. pp. 41–5. 76. Mimura S, Otani T, Okuda S. Photodynamic therapy for superficial esophageal cancer using an excimer dye laser. Diagn Ther Endosc 1994;1:99–105. 77. Mlkvy P. [Photodynamic therapy of gastrointestinal tumours – a pilot study.] Lekarsky Obzor 2003;52:171–5. 78. Moghissi K. Comparison of endoscopic PDT with surgical resection for early oesophageal cancer. Photodiag Photodyn Ther 2008;5:A O-12. 79. Moghissi K, Dixon K. Photodynamic therapy (PDT) in esophageal cancer: a surgical view of its indications based on 14 years experience. Technol Cancer Res Treat 2003;2:319–26. 80. Moghissi K, Dixon K. The role of photodynamic therapy (PDT) in pre-malignant and malignant oesophageal lesions: can PDT compete with surgery? Laser Helsinki 2008, 13th International Congress of EMLA (European Medical Laser Association) in conjunction with EMLA Finland and MAL (Medical Acupuncture and Laser) in cooperation with ASLMS (American Society for Laser Medicine and Surgery); 2008; Helsinki. 2008. 81. Moghissi K, Dixon K, Hudson E, Stringer M. Photodynamic therapy of oesophageal cancer. Lasers Med Sci 1995;10:67–71. 82. Moghissi K, Dixon K, Thorpe JA, Stringer M, Moore PJ. The role of photodynamic therapy (PDT) in inoperable oesophageal cancer. Eur J Cardiothorac Surg 2000;17:95–100. 83. Moghissi K, Dixon K, Thorpe JAC, Stringer MR. The role of photodynamic therapy (PDT) in oesophageal pre-neoplastic and malignant neoplastic lesions of the oesophagus: a review study. Photodynamic Therapy and Photodiagnosis in Clinical Practice, Brixen/ Bressanone, 7–11 October 2008. Session 6 – invited lecture. 84. Monnier P, Fontolliet C, Wagnieres G, Braichotte D, Vandenbergh H. Further appraisal of PDI and PDT of early squamous-cell carcinomas of the pharynx, esophagus and bronchi. Photodyn Ther Biomed Lasers 1992;1011:7–14. 85. Monnier P, Savary M, Fontolliet C, Wagnieres Chatelain GA, Cornaz P, Depeursinge C, et al. Photodetection and photodynamic therapy of ‘early’ squamous cell carcinomas of the pharynx, oesophagus and tracheo-bronchial tree. Lasers Med Sci 1990;5:149–68. 86. Monnier P, Savary M, Fontolliet C, Wagnieres G, Vandenbergh H, Chatelain A. Photodynamic therapy (PDT) of 25 early pharyngoesophageal carcinomas: results and complications. Dis Esophagus 1990;1:359–71. 87. Muto M, Yano T, Katada C, Mera K, Doi T, Ishikura S, et al. Salvage photodynamic therapy (PDT) for locoregional failure after definitive chemoradiotherapy (CRT) for esophageal cancer (EC). J Clin Oncol 2004;22:4171. 88. Nakamura T, Fukui H, Shirakawa K, Fujii Y, Fujimori T, Terano A. Photodynamic therapy of superficial esophageal cancer with a transparent hood. Gastrointest Endosc 2004;60:120–4. 89. Norberto L, Segalin A, Ruol A, Baessato M, Cusumano A, Bardini R, et al. Results after ND:YAG laser therapy and photo dynamic therapy (PDT) of
DOI: 10.3310/hta14370 Health Technology Assessment 2010; Vol. 14: No. 37 inoperable esophageal and cardial cancers. Recent Advances in Bronchoesophagology, Proceedings of the 6th World Congress of Bronchoesophagology, 1990, pp. 191–7. 90. Okunaka T, Kato H, Conaka C, Yamamoto H, Bonaminio A, Eckhauser ML. Photodynamic therapy of esophageal carcinoma. Surg Endosc 1990;4:150–3. 91. Okushima N, Muto Y, Kaburagi Y, Muroi M, Ide H, Suzuki S, et al. [Photodynamic therapy: its application for the treatment of esophageal cancer.] Nippon Geka Gakkai Zasshi 1989;90:1594–7. 92. Okushima N, Yoshida M, Muroi M. [Endoscopic photoradiation therapy for esophageal cancer.] Gastroenterol Endosc 1985;27:177–83. 93. Orth K, Ruck A, Beck G, Stanescu A, Beger HG. [Photodynamic therapy of small adenocarcinomas with methylene blue.] Chirurgie 1995;66:1254–7. 94. Orth K, Ruck A, Stanescu A, Beger HG. Intraluminal treatment of inoperable oesophageal tumours by intralesional photodynamic therapy with methylene blue. Lancet 1995;345:519–20. 95. Orth K, Stanescu A, Ruck A, Russ D, Beger HG. [Photodynamic ablation and argon-plasma coagulation of premalignant and early-stage malignant lesions of the oesophagus: an alternative to surgery?] Chirurgie 1999;70:431–8. 96. Overholt BF, Panjehpour M. Photodynamic therapy in Barrett’s esophagus: reduction of specialized mucosa, ablation of dysplasia, and treatment of superficial esophageal cancer. Semin Surg Oncol 1995;11:372–6. 97. Overholt BF, Panjehpour M. Barretts esophagus: photodynamic therapy for ablation of dysplasia, reduction of specialized mucosa and treatment of superficial esophageal cancer. SPIE Proceedings Series 1995;2371:375–84. 98. Overholt BF, Panjehpour M. Photodynamic therapy in Barrett’s esophagus. J Clin Laser Med Surg 1996;14:245–9. 99. Overholt BF, Panjehpour M. Photodynamic therapy for Barrett’s esophagus: clinical update. Am J Gastroenterol 1996;91:1719–23. 100. Overholt BF, Panjehpour M, Ayres M. Photodynamic therapy for Barrett’s esophagus: cardiac effects. Lasers Surg Med 1997;21:317–20. 101. Overholt BF, Panjehpour M, Halberg DL. Photodynamic therapy for Barrett’s esophagus with dysplasia and/or early stage carcinoma: long-term results. Gastrointest Endosc 2003;58:183–8. © 2010 Queen’s Printer and Controller of HMSO. All rights reserved. 102. Overholt BF, Panjehpour M, Haydek JM. Photodynamic therapy for Barrett’s esophagus: follow-up in 100 patients. Gastrointest Endosc 1999;49:1–7. 103. Overholt BF, Panjehpour M, Teffetellar E, Rose M. Photodynamic therapy (PDT) utilizing photofrin for treatment of early esophageal cancer. SPIE Proceedings Series 1993;1881:35–40. 104. Pan LN, Zhang ZY, Li M, Su RL. [Effect of photodynamic therapy for esophageal carcinoma in near future.] World Chin J Digestol 2006;14:530–2. 105. Panjehpour M, Overholt BF, Haydek JM, Dougherty TJ. Photodynamic therapy with photofrin followed by thermal ablation for elimination of dysplasia and early cancer in Barrett’s esophagus: follow-up in 100 patients. SPIE Proceedings Series 1998;3247:14–24. 106. Patrice T, Foultier MT, Yactayo S, Adam F, Galmiche JP, Douet MC, et al. Endoscopic photodynamic therapy with hematoporphyrin derivative for primary treatment of gastrointestinal neoplasms in inoperable patients. Digestive Diseases & Sciences 1990;35:545–52. 107. Patrice T, Foultier MT, Yactayo S, Douet MC, Maloisel F, Le Bodic L. Endoscopic photodynamic therapy with haematoporphyrin derivative in gastroenterology. J Photochem Photobiol B 1990;6:157–65. 108. Pazurek M, Malecka-Panas E. Photodynamic therapy in the palliative treatment of esophageal cancer. Photodiag Photodyn Ther 2005;2:73–7. 109. Peters F, Kara M, Rosmolen W, Aalders M, Ten Kate F, Krishnadath K, et al. Poor results of 5-aminolevulinic acid-photodynamic therapy for residual high-grade dysplasia and early cancer in barrett esophagus after endoscopic resection. Endoscopy 2005;37:418–24. 110. Privalov VA, Lappa AV, Seliverstov OV, Faizrakhmanov AB, Yarovoy NN, Kochneva EV, et al. Clinical trials of a new chlorin photosensitizer for photodynamic therapy of malignant tumors. Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XI 2002;4612:178–89. 111. Radu A, Grosjean P, Fontolliet C, Wagnieres G, Woodtli A, Bergh HV, et al. Photodynamic therapy for 101 early cancers of the upper aerodigestive tract, the esophagus, and the bronchi: a singleinstitution experience. Diagn Ther Endosc 1999;5:145–54. 112. Rahmani EY, Rex DK, Ciaccia D, Turpin CS. Photodynamic therapy for ablation of esophageal 161
Page 1 and 2: Appendices July 2010 10.3310/hta143
Page 3 and 4: DOI: 10.3310/hta14370 Health Techno
Page 9: DOI: 10.3310/hta14370 Health Techno
Page 12 and 13: 140 Appendix 6 18. Biel MA. Photody
Page 14 and 15: 142 Appendix 6 63. Gonzalez-Perez R
Page 16 and 17: 144 Appendix 6 treated with photody
Page 18 and 19: 146 Appendix 6 aminolevulinic acid
Page 20 and 21: 148 Appendix 6 carcinomas: 5 years
Page 38 and 39: 166 Appendix 9 photodynamic therapy
Page 40 and 41: 168 Appendix 9 of early-stage lung
Page 42 and 43: 170 Appendix 9 107. Okunaka T, Kato
Page 44 and 45: 172 Appendix 9 152. Kato H, Konaka
Page 54 and 55: 182 Appendix 12 as salvage treatmen
Page 56 and 57: 184 Appendix 12 63. Lorenz KJ, Maie
Page 58 and 59: 186 Appendix 12 107. Biel MA. Photo
Page 60 and 61: 188 Appendix 13 Study details Popul
Page 82 and 83:
210 Appendix 13 Study details Popul
Page 84 and 85:
Page 86 and 87:
Appendix 13 214 Study details Popul
Page 89 and 90:
DOI: 10.3310/hta14370 Health Techno
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
Page 101 and 102:
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
Page 113 and 114:
Page 115 and 116:
Page 117 and 118:
Page 119 and 120:
Page 121 and 122:
Page 123 and 124:
Page 125 and 126:
Page 127 and 128:
Page 129 and 130:
Page 131 and 132:
Page 133 and 134:
Page 135 and 136:
Page 137 and 138:
Page 139 and 140:
Page 141 and 142:
Page 143 and 144:
Study details Population details Tr
Page 145 and 146:
Page 147 and 148:
Page 149 and 150:
Page 151 and 152:
Page 153:
Page 156 and 157:
Page 158 and 159:
Appendix 21 286 Study details Popul
Page 162:
Feedback The HTA programme and the
show all

APPENDICES - NIHR Health Technology Assessment Programme

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?